The FDA commissioner's effort to shorten the review of drugs favored by the Trump administration is causing alarm across the ...
AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, recently announced that the United States Food and Drug Administration (FDA) has ...
A liberal journalist says ICE accepted her recruitment application despite being an outspoken critic of the Trump ...
Shares of GH Research rose on plans to provide an update on the status of its investigational new drug application for GH001, a therapy for treatment-resistant depression. The stock climbed 19% to $15 ...
GH Research plans to provide an update on the status of its investigational new drug application for GH001, a therapy for treatment-resistant depression. The biopharmaceutical company said Friday it ...
Medicare costs could decrease under a new proposal from the Trump administration that would shift the drug payment model entirely. The Centers for Medicare & Medicaid Services (CMS) released details ...
The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs ...
President Donald Trump says it's the biggest thing to happen to drug pricing. The White House says 9 drug manufacturers have agreed to give Medicaid in all 50 states access to most favored nation ...
NANJING, China and GAITHERSBURG, Md., Dec. 19, 2025 /PRNewswire/ -- TransThera Sciences Nanjing, Inc. (the "TransThera") announced that the new drug application for Tinengotinib tablets has been ...
Novo Nordisk A/S (NYSE: NVO) on Thursday submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for once-weekly CagriSema. The application covers CagriSema for use with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results